Hims guides Q1 revenue below expectations with sharp EPS drop amid market volatility.

Hims & Hers Health forecasted Q1 revenue between $600 million and $625 million, slightly below the Street's $616–650 million estimate, impacted by a $65 million GLP-1 headwind. The company expects GAAP EPS to fall about 83% year-over-year to roughly $0.03, signaling a margin reset already factored into current estimates. Despite this, short interest remains high at about 34% of the float, with 2–3 days to cover, suggesting potential for increased stock volatility. Valuation metrics stand at approximately 2.3 times 2026 sales and 53 times forward P/E, indicating the need for business stabilization and margin recovery to justify current prices.